서울바이오시스

092190KOSDAQ반도체 제조업

48.0 / 100

Reference Date: 2026-07-24

Financial Score16.5 / 40

News Sentiment12.5 / 25

Momentum9.0 / 20

Disclosure10.0 / 15

AI Analysis: PBR is undervalued vs. peers but the high debt ratio poses financial risk. Plunged 23.4% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Seoul Biosys provides comprehensive solutions ranging from UV to IR, laser diodes, and VCSELs through six global R&D centers and production infrastructure, with over 7,000 patents protecting its 200nm–1600nm wavelength optical semiconductor technology. The company leads in key markets such as automotive lighting and UV LED, where it holds the top market share, and is projected to grow at a 12% annual rate across six major industries including micro LED and VCSEL.

Number of Employees

193people

Average Salary

60.2M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 26.174.0Point

PBR

1.52Industry Average 1.604.0Point

In line with industry avg

ROE

-8.97Industry Average -3.923.5Point

2.3x industry avg (excellent)

Debt Ratio

38.40Industry Average 14.750.0Point

2.6x industry avg (risky)

Trend 2023~20255.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲24.0% (2-year basis)

Operating Profit Growth Rate

2.0 / 3

Avg ▲5.6% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -23.7% (improving, 3yr)

Detailed News Sentiment

1 totalPositive 0Neutral 1Negative 0Average Sentiment Score 50

Neutral
디스플레이協, 무기발광 디스플레이 정례회의서 정책 지원 논의
회의는 무기발광 디스플레이 분야의 시장 동향과 경쟁력 강화를 위한 논의가 이루어졌으나, 서울바이오시스(092190)에 직접적인 영향은 제한적이다.

Detailed Momentum

52-week position3.0Point

52w lower range (22%)

Current 5,630Won52-week high 17,57052-week low 2,185

1-month return0.0Point

1m -23.40% (strong drop)

Volume trend6.0Point

Volume increasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral연결재무제표기준영업(잠정)실적(공정공시)2026-07-13